EP3319993
Samtengd AXL-sérvirk mótefni - lyf til að mehöndla krabbamein
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.7.2016EP published:
15.1.2020EP application number:
16739079.8
EP translation filed:
2.4.2020Grant published:
15.4.2020EPO information:
European Patent Register
Max expiry date:
7.7.2036Expiry date:
7.7.2026Next due date:
31.7.2026
Title:
AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT
Timeline
Today
8.7.2016EP application
15.1.2020EP Publication
2.4.2020Translation submitted
15.4.2020Registration published
7.7.2026Expires
Owner
Name:
Genmab A/SAddress:
Carl Jacobsens Vej 30, 2500, Valby, DK
Inventor
Name:
BOSHUIZEN, JuliaAddress:
1058-NC Amsterdam, NL
Name:
JACOBSEN, KirstineAddress:
5000 Odense, DK
Name:
BREIJ, EstherAddress:
3584 CT Utrecht, NL
Name:
KOOPMAN, LouiseAddress:
3584 CT Utrecht, NL
Name:
SATIJN, DavidAddress:
3584 CT Utrecht, NL
Name:
VAN DEN BRINK, EdwardAddress:
3584 CT Utrecht, NL
Name:
VERZIJL, DennisAddress:
3584 CT Utrecht, NL
Name:
DE JONG, RobAddress:
3584 CT Utrecht, NL
Name:
VAN DIJKHUIZEN RADERSMA, RiemkeAddress:
3584 CT Utrecht, NL
Name:
PEEPER, DanielAddress:
1183-DN Amstelveen, NL
Name:
DITZEL, Henrik JørnAddress:
8660 Skanderborg, DK
Name:
PARREN, PaulAddress:
3984 PR Odijk, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/EP2015/065900Date:
10.7.2015Country:
WO
Number:
201662278283 PDate:
13.1.2016Country:
US
Classification
Categories:
C07K 16/28, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 12.6.2020
Expires: 7.7.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 8.6.2021
Expires: 7.7.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 9.6.2022
Expires: 7.7.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 11.6.2023
Expires: 7.7.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.6.2024
Expires: 7.7.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 4.7.2025
Expires: 7.7.2026
Payer: Árnason Faktor ehf.